IOXILAN for Percutaneous coronary intervention: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 19 adverse event reports in the FDA FAERS database where IOXILAN was used for Percutaneous coronary intervention.
Most Reported Side Effects for IOXILAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Urticaria | 36 | 30.3% | 0 | 4 |
| Vomiting | 19 | 16.0% | 0 | 0 |
| Pruritus | 16 | 13.5% | 1 | 1 |
| Nausea | 15 | 12.6% | 0 | 0 |
| Hypersensitivity | 12 | 10.1% | 0 | 1 |
| Rash | 11 | 9.2% | 0 | 2 |
| Contrast media reaction | 8 | 6.7% | 1 | 0 |
| Dyspnoea | 8 | 6.7% | 1 | 2 |
| Sneezing | 8 | 6.7% | 0 | 1 |
| Throat tightness | 8 | 6.7% | 0 | 2 |
| Chest pain | 7 | 5.9% | 0 | 3 |
| Hypotension | 5 | 4.2% | 1 | 2 |
| Post procedural haematoma | 5 | 4.2% | 0 | 5 |
Other Indications for IOXILAN
Other Drugs Used for Percutaneous coronary intervention
PRASUGREL (376)
CLOPIDOGREL BISULFATE (356)
TICAGRELOR (297)
ASPIRIN (227)
BIVALIRUDIN (159)
CANGRELOR (94)
HEPARIN (86)
ABCIXIMAB (49)
INVESTIGATIONAL PRODUCT (46)
IODIXANOL (29)